# Intuitive Surgical, Inc. (ISRG) — Q2-2026 Earnings Preview

**Report date:** 2026-07-21 (after market close)  
**Sector:** Health Care / Health Care Equipment  
**Status:** upcoming  
**Source:** https://earningsnxt.ai/ticker/ISRG/earnings/Q2-2026

## Analyst Estimates

- **Consensus EPS:** $2.50 (range $2.41–$2.60)
- **Consensus revenue:** $2818.79

## Pre-Earnings Brief

### Company Snapshot

Intuitive Surgical, Inc. (ISRG) is a leader in the health care equipment sector, known for its innovative robotic surgical systems. These systems enhance precision in surgeries, which is increasingly important as the demand for minimally invasive procedures grows.

### Key Metrics to Watch

- **Earnings Per Share (EPS)** (consensus $2.50) — EPS is a key indicator of the company's profitability and financial health, and investors will be looking for continued growth.
- **Revenue** (consensus $2.8B) — Revenue growth reflects the company's ability to sell its products and services, which is crucial for sustaining its market position.

### Last Quarter Recap

In Q1-2026, Intuitive Surgical reported an EPS of $2.50, significantly beating estimates by 53.66%. However, the stock experienced a slight decline of 3.07% the following day.

**Management promises last quarter:**

- Continued focus on expanding product offerings.
- Investment in R&D to enhance surgical technologies.
- Commitment to improving operational efficiency.

### Wall Street Expectations

Analysts expect Intuitive Surgical to report strong earnings, with a consensus EPS of $2.50 and revenue of $2.8B. The company has a solid track record of beating EPS estimates, which raises expectations for this quarter.

**Bull case:** If Intuitive Surgical exceeds the EPS estimate and shows strong revenue growth, it could signal robust demand for its surgical systems, potentially leading to a positive market reaction.

**Bear case:** Conversely, if the company fails to meet expectations or provides cautious guidance, it could raise concerns about future growth, leading to a negative impact on the stock.

### Options Signal

Implied move: **1.9%**

The options market is pricing in a modest move of about 1.9% following the earnings announcement, indicating uncertainty among investors.

### Earnings Track Record

| Quarter | EPS Surprise | 1-Day Reaction |
|---|---|---|
| Q1-2026 | +53.66% | -3.07% |
| Q4-2025 | +38.18% | +0.40% |
| Q3-2025 | +51.90% | +0.93% |
| Q2-2025 | +43.51% | -0.99% |
| Q1-2025 | +32.80% | +2.22% |

### Pivotal Questions

1. **Will the EPS exceed $2.50, and what factors contributed to this result?**
   - Why it matters: A strong EPS could reinforce investor confidence and suggest continued demand for Intuitive's products.
2. **What is the revenue outlook for the upcoming quarters?**
   - Why it matters: Guidance on revenue growth will be critical for assessing the company's future performance and market position.

### Thesis Break Levels

- **Bull trigger:** An EPS above $2.50, driven by strong sales growth in robotic systems, would confirm the bull case.
- **Bear trigger:** An EPS below $2.50 or negative guidance would confirm the bear case.

The debate centers around whether Intuitive Surgical can sustain its growth trajectory amid increasing competition and market dynamics.

### Scenario Playbook

- **Beat & raise:** If Intuitive Surgical beats expectations, history suggests the stock could rise by around 1.36% on the first day, confirming strong demand and operational efficiency.
- **In-line / cautious:** If results are in line with expectations but management provides cautious commentary, the stock may see muted movement as investors reassess future growth.
- **Miss:** If the company misses expectations, history suggests a potential decline of around 0.47%, indicating investor disappointment.

### What the Street is Missing

The Street may be underestimating the potential for Intuitive Surgical to capture market share in robotic surgeries, which could lead to stronger-than-expected revenue growth.

**Supporting points:**

- The company has consistently beaten EPS estimates, indicating stronger operational performance.
- Recent trends in minimally invasive surgeries suggest increasing demand for robotic systems.
- The options market is pricing a modest move, which may not fully reflect the company's growth potential.

**Risk to consensus:** If revenue growth significantly exceeds $2.8B, it could challenge the current consensus outlook.

### What to Listen For

- Any updates on new product launches or enhancements to existing systems.
- Insights into market demand for robotic surgeries.
- Management's outlook on revenue growth for the next quarters.
- Comments on competitive pressures and how the company plans to address them.
- Updates on international market expansion efforts.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/ISRG/earnings/Q2-2026_